Vertex Pharmaceuticals Incorporated
IT ˙ BIT ˙ US92532F1003
366,30 € ↓ -1,30 (-0,35%)
2026-06-03
DEL PRIS
SecurityIT:1VRTX / Vertex Pharmaceuticals Incorporated
InstitutionOptas, LLC
Latest Disclosed Ownership1,160 shares
Latest Disclosed Value $ 517,989
Optas, LLC reports 12.08% increase in ownership of 1VRTX / Vertex Pharmaceuticals Incorporated

On April 24, 2026 - Optas, LLC filed a 13F-HR form disclosing ownership of 1,160 shares of Vertex Pharmaceuticals Incorporated (IT:1VRTX) valued at $440,336 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 27, 2026 disclosing 1,035 shares of Vertex Pharmaceuticals Incorporated. This represents a change in shares of 12.08% during the quarter. The current value of the position is $424,908 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-24 2026-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,160 125 12.08 518 10.23 0.0454
2026-01-27 2025-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,035 271 35.47 469 56.86 0.0734
2025-10-15 2025-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 764 -143 -15.77 299 -25.81 0.0508
2025-07-23 2025-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 907 -875 -49.10 404 -53.30 0.0767
2025-04-17 2025-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,782 908 103.89 864 145.87 0.1503
2025-01-24 2024-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 874 64 7.90 352 -6.65 0.0758
2024-10-29 2024-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 810 37 4.79 377 3.87 0.0866
2024-07-25 2024-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 773 19 2.52 362 14.92 0.0933
2024-04-18 2024-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 754 9 1.21 315 3.96 0.0860
2024-01-26 2023-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 745 10 1.36 303 18.82 0.0912
2023-10-31 2023-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 735 19 2.65 256 1.59 0.0851
2023-07-20 2023-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 716 9 1.27 252 13.06 0.0843
2023-04-18 2023-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 707 707 223 0.0795
2021-01-27 2020-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 0 -1,351 -100.00 0 -100.00
2020-10-23 2020-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,351 469 53.17 367 43.36 0.1121
2020-07-31 2020-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 882 -135 -13.27 256 6.22 0.1037
2020-04-14 2020-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,017 9 0.89 241 9.55 0.1201
2020-02-14 2019-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,008 1,008 220 0.0849
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.